UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

BMC cancer, 2009-01, Vol.9 (1), p.8-8, Article 8

2009

Volltextzugriff (PDF)

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

Acta obstetricia et gynecologica Scandinavica, 2012-04, Vol.91 (4), p.496-502

2012

Volltextzugriff (PDF)

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Cancer medicine (Malden, MA), 2014-10, Vol.3 (5), p.1294-1301

2014

Volltextzugriff (PDF)

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-01, Vol.121 (1), p.38-44

2013

Volltextzugriff (PDF)

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-Control Study

Cancer causes & control, 2006-08, Vol.17 (6), p.821-829

2006

Volltextzugriff (PDF)

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab

PloS one, 2014-10, Vol.9 (10), p.e109430

2014

Volltextzugriff (PDF)

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Cancer, 2003-07, Vol.98 (1), p.66-73

2003

Volltextzugriff (PDF)

Serum YKL-40 and gestational diabetes - an observational cohort study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.770-775

2016

Volltextzugriff (PDF)

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2006-10, Vol.114 (10), p.675-681

2006

Volltextzugriff (PDF)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-05, Vol.116 (5), p.400-409

2008

Volltextzugriff (PDF)

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2003-03, Vol.82 (3), p.287-293

2003

Volltextzugriff (PDF)

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study

Gynecologic oncology, 2007-03, Vol.104 (3), p.508-515

2007

Volltextzugriff (PDF)

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma study

Cancer, 2004-06, Vol.100 (11), p.2387-2395

2004

Volltextzugriff (PDF)

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Gynecologic oncology, 2011-11, Vol.123 (2), p.308-313

2011

Volltextzugriff (PDF)

Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4051-4058

2004

Volltextzugriff (PDF)

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass

Gynecologic oncology, 2015-09, Vol.138 (3), p.640-646

2015

Volltextzugriff (PDF)

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2015-05, Vol.123 (5), p.401-409

2015

Volltextzugriff (PDF)

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-12, Vol.121 (12), p.1177-1186

2013

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-10, Vol.120 (10), p.846-854

2012

Volltextzugriff (PDF)

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

Gynecologic oncology, 2012-11, Vol.127 (2), p.379-383

2012

Volltextzugriff (PDF)

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival

Oncology reports, 2003-09, Vol.10 (5), p.1535

2003

Volltextzugriff (PDF)

Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study

Pathology, 2008-08, Vol.40 (5), p.487-492

2008

Volltextzugriff (PDF)

The Prognostic Value of Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Stage III Ovarian Cancer Patients

Anticancer research, 2004-05, Vol.24 (3B), p.1981-1985

2004

Volltextzugriff (PDF)

K- ras alterations in Danish ovarian tumour patients. : From the danish “malova” ovarian cancer study

Gynecologic oncology, 2003-04, Vol.89 (1), p.31-36

2003

Volltextzugriff (PDF)

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients

Anticancer research, 2002-05, Vol.22 (3), p.1859

2002

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-Control Study

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Serum YKL-40 and gestational diabetes - an observational cohort study

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma study

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival

Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study

The Prognostic Value of Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Stage III Ovarian Cancer Patients

K- ras alterations in Danish ovarian tumour patients. : From the danish “malova” ovarian cancer study

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients

Aktive Filter

Suchergebnisse filtern